AstraZeneca News

Scientists from Oxford University and AstraZeneca, known for developing the COVID-19 vaccine, are now working on a vaccine for the bubonic plague. This initiative arises amid concerns regarding the potential emergence of a superbug strain of the Black Death. Military experts in the UK have suggested that the country should stockpile supplies of this new inoculation to prepare for possible future pandemics. The development reflects ongoing vigilance in public health as scientists aim to address emerging infectious disease threats.